FDA NDC Directory · JSON-LD · Markdown
NDC 65862-527 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA200834 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (37.5 mg/1) |
| Marketing started | 20110601 |
| Package count | 7 |
Source: openFDA. Public-domain (CC0).